CureMatch Recognized as Best Artificial Intelligence (AI) Company in Healthcare
CureMatch CEO as Featured Healthcare & AI Speaker at LES Event in San Diego
FOR IMMEDIATE RELEASE
SAN DIEGO, CA – July 12, 2018 – CureMatch, Inc. has been recognized as having the “Best AI-based Solution for Healthcare” by AI Breakthrough, an independent organization that recognizes the top companies, technologies, and products in the global Artificial Intelligence (AI) market. The CureMatch precision medicine technology utilizes machine learning features and rules-based decision support to offer ranked combination cancer treatment options and has succeeded in pushing ingenuity to be identified as one of the best AI solutions in 2018.
The AI Breakthrough Awards program attracted over 2,500 nominations from over 15 different countries, and winning companies were selected based on a variety of criteria, including the most innovative and technologically advanced products and services. CureMatch is one of only 31 award winners, with the “Best Overall AI Company” award given to Google.
“The global AI market is expected to be worth over seven billion dollars this year, and the industry is growing exponentially with numerous exciting technological developments progressing daily,” said James Johnson, managing director at AI Breakthrough. “With this amazing rate of market growth and development, AI Breakthrough is determined to recognize the standout AI solutions and companies.”
“CureMatch is thrilled to be highlighted as an AI visionary in healthcare, as the cure for cancer lies in technology,” stated Stephane Richard, Ph.D., CEO of CureMatch. “Oncologists around the globe, regardless of proximity to top cancer research centers, can receive world class therapeutic decision support with CureMatch.”
CureMatch CEO, Stephane Richard, Ph.D., is also a featured speaker at the Healthcare and Artificial Intelligence event by the Licensing Executives Society (LES). Sponsored by the UC San Diego’s Office of Innovation and Commercialization, Sanford Consortium for Regenerative Medicine, and Knobbe Martens, the presentation will cover specific perspectives and trends in the nascent yet expanding arena of AI-based healthcare.
Registration is open ($25 non-member) for this event on Thursday, July 12 starting at 6pm at the Roth Auditorium in La Jolla, CA.
About AI Breakthrough
Part of the Tech Breakthrough Awards organization, the AI Breakthrough Awards program is devoted to honoring excellence in Artificial Intelligence technologies, services, companies, and products. The AI Breakthrough Awards provide public recognition for the achievements of AI companies and products in categories including AI Platforms, Robotics, Business Intelligence, AI Hardware, NLP, Vision, Biometrics, industry vertical AI applications and more. For more information visit AIBreakthroughAwards.com
About Licensing Executives Society (LES)
LES (USA & Canada) is a member society of the Licensing Executives Society International, Inc. (LESI), with a worldwide membership of over 9,000 professionals across 32 national societies located in more than 90 countries. For more than 50 years, LES has been the leading association for intellectual property, technology, and business development professionals to achieve professional and personal success.
CureMatch, Inc. is a digital precision oncology company bridging the gap between legacy cancer treatments and advances in personalized medicine. Utilizing proprietary algorithms to analyze over 4.5 million combinations of commonly used as well as newly approved cancer treatments found in massive pharmacological and clinical databases, CureMatch scores and ranks Personalized Combination Therapy® options to target specific molecular aberrations and improve the precision of cancer treatment recommendations. This actionable intelligence guides oncologists to effectively customize treatment for each individual patient. Based in San Diego, CA, the CureMatch technology has expert foundation in supercomputing, oncology, genetics, molecular and cell biology. For more information, visit https://www.curematch.com
Name: Larissa Anderson